Dr Sarah French, MD | |
1009 City Ave N, Ripley, MS 38663 | |
(662) 837-1404 | |
(662) 837-3760 |
Full Name | Dr Sarah French |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 17 Years |
Location | 1009 City Ave N, Ripley, Mississippi |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730386608 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 22010 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baptist Memorial Hospital Union County | New albany, MS | Hospital |
North Mississippi Medical Center | Tupelo, MS | Hospital |
Magnolia Regional Health Center | Corinth, MS | Hospital |
Tippah County Hospital | Ripley, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Primary Care Clinic Of Ripley Pa | 5698761302 | 4 |
News Archive
A gene thought to be associated with cancer development can be a tumor suppressor gene in mice, researchers have discovered. Understanding which genes are involved in spreading cancer could lead to future therapies.
Advancing the treatment of peripheral artery disease, Medtronic, Inc. today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant Cobalt Iliac Balloon-Expandable Stent System.
It is time to begin open discussions about how to deal with expensive, minimally effective, medical care with patients, families, professionals and ethicists and not the medical industrialists who gain from prolonging life at every expense.
"The GAVI Alliance has announced that it will include human papillomavirus (HPV) and combined measles-rubella vaccines in its portfolio for the first time" to help protect women from cervical cancer and children from disability or premature death, Africa Science News reports.
The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC), researchers announced at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.
› Verified 6 days ago
Entity Name | Primary Care Clinic Of Ripley Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356312623 PECOS PAC ID: 5698761302 Enrollment ID: O20040420001420 |
News Archive
A gene thought to be associated with cancer development can be a tumor suppressor gene in mice, researchers have discovered. Understanding which genes are involved in spreading cancer could lead to future therapies.
Advancing the treatment of peripheral artery disease, Medtronic, Inc. today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant Cobalt Iliac Balloon-Expandable Stent System.
It is time to begin open discussions about how to deal with expensive, minimally effective, medical care with patients, families, professionals and ethicists and not the medical industrialists who gain from prolonging life at every expense.
"The GAVI Alliance has announced that it will include human papillomavirus (HPV) and combined measles-rubella vaccines in its portfolio for the first time" to help protect women from cervical cancer and children from disability or premature death, Africa Science News reports.
The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC), researchers announced at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sarah French, MD 1009 City Ave N, Ripley, MS 38663-1414 Ph: (662) 837-1404 | Dr Sarah French, MD 1009 City Ave N, Ripley, MS 38663 Ph: (662) 837-1404 |
News Archive
A gene thought to be associated with cancer development can be a tumor suppressor gene in mice, researchers have discovered. Understanding which genes are involved in spreading cancer could lead to future therapies.
Advancing the treatment of peripheral artery disease, Medtronic, Inc. today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant Cobalt Iliac Balloon-Expandable Stent System.
It is time to begin open discussions about how to deal with expensive, minimally effective, medical care with patients, families, professionals and ethicists and not the medical industrialists who gain from prolonging life at every expense.
"The GAVI Alliance has announced that it will include human papillomavirus (HPV) and combined measles-rubella vaccines in its portfolio for the first time" to help protect women from cervical cancer and children from disability or premature death, Africa Science News reports.
The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC), researchers announced at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.
› Verified 6 days ago